Publications


2016

Association of infertility and fertility treatment with mammographic density in a large screening-based cohort of women: a cross-sectional study.

Frida E. Lundberg, Anna L. V. Johansson, Kenny Rodriguez-Wallberg, Judith S. Brand, Kamila Czene, Per Hall, Anastasia N. Iliadou.


Brest Cancer Res
201604
https://pubmed.ncbi.nlm.nih.gov/27072636/

Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosis. 

Brand JS, Colzani E, Johansson AL, Giesecke J, Clements M, Bergh J, Hall P, Czene K.


J Infect
201604
https://pubmed.ncbi.nlm.nih.gov/27063280/

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. 

Zhao Z, Wen W, Michailidou K, Bolla MK, Wang Q, Zhang B, Long J, Shu XO, Schmidt MK, Milne RL, García-Closas M, et al.


Cancer Causes Control
201604
https://pubmed.ncbi.nlm.nih.gov/27053251/

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. 

Dunning AM, Michailidou K, Kuchenbaecker KB, Thompson D, French JD, Beesley J, Healey CS, et al.


Nat Genet
201602
https://pubmed.ncbi.nlm.nih.gov/26928228/

No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing.

Easton DF, Lesueur F, Decker B, Michailidou K, Li J, Allen J, Luccarini C, Pooley KA, et al.


J Med Genet
201602
https://pubmed.ncbi.nlm.nih.gov/26921362/

Genetic predisposition to ductal carcinoma in situ of the breast.

Christos Petridis, Mark N. Brook, Vandna Shah, Kelly Kohut, Patricia Gorman, Michele Caneppele, et al.


Breast Cancer Res
201602
https://pubmed.ncbi.nlm.nih.gov/26884359/

2015

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Seibold P, Schmezer P, Behrens S, Michailidou K, Bolla MK, Wang Q, Flesch-Janys D, et al.


BMC Cancer
201512
https://pubmed.ncbi.nlm.nih.gov/26674097/

Associations of Breast Cancer Risk Prediction Tools With Tumor Characteristics and Metastasis. 

Holm J, Li J, Darabi H, Eklund M, Eriksson M, Humphreys K, Hall P, Czene K.


J Clin Oncol
201511
https://pubmed.ncbi.nlm.nih.gov/26628467/

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium.

Jieping Lei, Anja Rudolph, Kirsten B. Moysich, Sabine Behrens, Ellen L. Goode, Manjeet K. Bolla, Joe Dennis, Alison M. Dunning, et al.


Hum Genet
201511
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4698282/

SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival. 

Jamshidi M, Fagerholm R, Khan S, Aittomäki K, Czene K, Darabi H, Li J, Andrulis IL, et al.


Oncotarget
201511
https://pubmed.ncbi.nlm.nih.gov/26317411/

Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. 

O’Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J; Australian National Endometrial Cancer Study Group (ANECS), et al.


Endocr Relat Cancer
201510
https://pubmed.ncbi.nlm.nih.gov/26330482/

In Search for the Genetic Basis of Quality of Life in Healthy Swedish Women-A GWAS Study Using the iCOGS Custom Genotyping Array.

Schoormans D, Darabi H, Li J, Brandberg Y, Eriksson M, Zwinderman KH, Sprangers MA, Hall P.


PLoS One
201510

Large-scale genomic analyses link reproductive aging to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair. 

Day FR, Ruth KS, Thompson DJ, Lunetta KL, Pervjakova N, Chasman DI, Stolk L, Finucane HK, et al.


Nat Genet
201509
https://pubmed.ncbi.nlm.nih.gov/26414677/

Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer risk.

Guo X, Long J, Zeng C, Michailidou K, Ghoussaini M, Bolla MK, Wang Q, Milne RL, et al.


Cancer Epidemiol Biomarkers Prev.
201509
https://pubmed.ncbi.nlm.nih.gov/26354892/

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data. 

Abrahamsson L, Czene K, Hall P, Humphreys K.


Breast Cancer Res
201508
https://pubmed.ncbi.nlm.nih.gov/26293658/

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Ben Zhang, Xiao-Ou Shu, Ryan J. Delahanty, Chenjie Zeng, Kyriaki Michailidou, Manjeet K. Bolla, Qin Wang, et al.


J Natl Cancer Inst
201508
https://pubmed.ncbi.nlm.nih.gov/26296642/

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density.

Rudolph A, Fasching PA, Behrens S, Eilber U, Bolla MK, Wang Q, Thompson D, Czene K, et al.


Breast Cancer Res
201508
https://pubmed.ncbi.nlm.nih.gov/26275715/

2014

Breast cancer genetic risk profile is differentially associated with interval and screen-detected breast cancers.

Li J, Holm J, Bergh J, Eriksson M, Darabi H, Lindström LS, Törnberg S, Hall P, et al.


Ann Oncol
201412
https://pubmed.ncbi.nlm.nih.gov/25488685/